Intradermal Allergy Test

An intradermal allergy test is a diagnostic procedure where a minute quantity of sterile, diluted allergen extract is injected into the dermis (the layer of skin just beneath the epidermis). This test is significantly more sensitive than a skin prick test and is typically performed on the outer forearm or upper arm. Within 15 to 20 minutes, the injection sites are evaluated for a wheal (a raised, itchy bump) and flare (surrounding redness), which indicates a localized allergic response. Due to the risk of systemic allergic reactions (anaphylaxis), this procedure must be conducted by trained healthcare professionals in a facility equipped with emergency resuscitation equipment.

Dosage by Body Weight

Administered exclusively by a healthcare provider. The standard dose is 0.02 mL to 0.05 mL of a diluted allergen extract injected intradermally to produce a small, visible bleb (2-3 mm in diameter). A positive control (typically histamine) and a negative control (typically physiological saline) are injected simultaneously to validate the test results.

  1. Body Weight
    Below 5 kg
    Dose
    Not recommended
    Frequency
    Not applicable
    Tracking Notes
    Intradermal testing is not routinely performed on infants. Skin reactivity is highly variable and unreliable in this age group, and the risk of systemic reactions is elevated.
  2. Body Weight
    5-7 kg
    Dose
    0.02 mL
    Frequency
    Single diagnostic application
    Tracking Notes
    Rarely performed. Standardized volume (0.02 mL) is used if clinically indicated, but the total number of simultaneous tests must be minimized due to limited skin surface area.
  3. Body Weight
    8-10 kg
    Dose
    0.02 mL to 0.03 mL
    Frequency
    Single diagnostic application
    Tracking Notes
    Requires strict clinical justification. The number of tested allergens should be limited to prevent cumulative systemic absorption.
  4. Body Weight
    11-15 kg
    Dose
    0.02 mL to 0.05 mL
    Frequency
    Single diagnostic application
    Tracking Notes
    Standard diagnostic volume. Patient must be monitored closely for at least 30 minutes post-injection for signs of systemic allergic reactions.
  5. Body Weight
    16-20 kg
    Dose
    0.02 mL to 0.05 mL
    Frequency
    Single diagnostic application
    Tracking Notes
    Standard diagnostic volume. Ensure the patient has avoided antihistamines and other interfering medications for an appropriate period before testing.

Formulation

Injectable Solution

Purpose

Used as a highly sensitive diagnostic tool to identify specific environmental, venom, or drug allergens when standard skin prick testing yields negative or inconclusive results.

Generic Name

Allergenic Extracts (Intradermal)

Branded Drug Names

Intradermal Allergy Test is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:

Scheduled Drug

No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.

Alternatives

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.